Yoshitaka Isaka

17.8k total citations · 3 hit papers
395 papers, 12.2k citations indexed

About

Yoshitaka Isaka is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoshitaka Isaka has authored 395 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Nephrology, 109 papers in Molecular Biology and 51 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoshitaka Isaka's work include Chronic Kidney Disease and Diabetes (57 papers), Dialysis and Renal Disease Management (50 papers) and Renal Diseases and Glomerulopathies (49 papers). Yoshitaka Isaka is often cited by papers focused on Chronic Kidney Disease and Diabetes (57 papers), Dialysis and Renal Disease Management (50 papers) and Renal Diseases and Glomerulopathies (49 papers). Yoshitaka Isaka collaborates with scholars based in Japan, United States and Germany. Yoshitaka Isaka's co-authors include Enyu Imai, Yoshitsugu Takabatake, Tomonori Kimura, Hiromi Rakugi, Isao Matsui, Atsushi Takahashi, Takayuki Hamano, Yusuke Sakaguchi, Shiro Takahara and Tamotsu Yoshimori and has published in prestigious journals such as Cell, JAMA and Journal of Biological Chemistry.

In The Last Decade

Yoshitaka Isaka

375 papers receiving 12.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury

2013 467 citations Tomonori Kimura, Yoshitsugu Takabatake et al. profile →
Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy

2013 411 citations Tomonori Kimura, Yoshitsugu Takabatake et al. profile →
Autophagy Protects the Proximal Tubule from Degeneration and Acute Ischemic Injury

2011 380 citations Tomonori Kimura, Yoshitsugu Takabatake et al. Journal of the American Society of Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshitaka Isaka Japan	53	4.1k	4.1k	2.1k	1.3k	1.3k	395	12.2k
Xiao‐Ming Meng China	58	8.1k 2.0×	3.2k 0.8×	1.8k 0.9×	1.6k 1.2×	1.3k 1.0×	256	15.3k
Donald W. Bowden United States	59	4.1k 1.0×	3.2k 0.8×	1.9k 0.9×	2.0k 1.5×	1.0k 0.8×	359	14.7k
Hidenori Koyama Japan	68	5.9k 1.4×	1.8k 0.4×	1.4k 0.7×	1.7k 1.3×	1.4k 1.1×	414	15.1k
Joseph P. Grande United States	71	4.2k 1.0×	3.8k 0.9×	939 0.5×	2.8k 2.0×	1.5k 1.1×	284	15.0k
Jonathan Barasch United States	61	4.6k 1.1×	9.8k 2.4×	2.2k 1.1×	2.5k 1.9×	757 0.6×	113	17.5k
Robert Terkeltaub United States	77	5.9k 1.4×	6.3k 1.5×	1.3k 0.6×	3.3k 2.4×	1.2k 0.9×	269	17.7k
Masashi Mukoyama Japan	56	4.5k 1.1×	2.2k 0.5×	1.2k 0.6×	1.7k 1.2×	663 0.5×	259	15.3k
Takashi Wada Japan	55	3.2k 0.8×	2.9k 0.7×	1.1k 0.5×	2.0k 1.5×	745 0.6×	454	13.5k
Alexander Zarbock Germany	70	3.9k 1.0×	4.7k 1.1×	2.2k 1.1×	2.5k 1.8×	960 0.7×	288	17.7k
Manjeri A. Venkatachalam United States	51	4.5k 1.1×	3.1k 0.8×	784 0.4×	984 0.7×	1.0k 0.8×	116	9.6k

Countries citing papers authored by Yoshitaka Isaka

Since Specialization

Citations

This map shows the geographic impact of Yoshitaka Isaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Isaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Isaka more than expected).

Fields of papers citing papers by Yoshitaka Isaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Isaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Isaka. The network helps show where Yoshitaka Isaka may publish in the future.

Co-authorship network of co-authors of Yoshitaka Isaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Isaka. A scholar is included among the top collaborators of Yoshitaka Isaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Isaka. Yoshitaka Isaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaimori, Jun‐Ya, Yusuke Sakaguchi, Tatsufumi Oka, & Yoshitaka Isaka. (2025). Plant-Dominant Low-Protein Diets: A Promising Dietary Strategy for Mitigating Disease Progression in People with Chronic Kidney Disease—A Comprehensive Review. Nutrients. 17(4). 643–643. 1 indexed citations

Imaizumi, Takahiro, Hirotaka Komaba, Takayuki Hamano, et al.. (2025). Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study. Clinical Kidney Journal. 18(2). sfae398–sfae398. 3 indexed citations

Sakaguchi, Yusuke, Tatsufumi Oka, Yohei Doi, et al.. (2024). Association between urinary uric acid excretion and kidney outcome in patients with CKD. Scientific Reports. 14(1). 5119–5119. 9 indexed citations

Shinzawa, Maki, Isao Matsui, Yohei Doi, et al.. (2024). A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in Japan. Kidney International. 107(3). 530–540. 6 indexed citations

Ishii, Chiharu, Takeyuki Akita, Tomonori Kimura, et al.. (2024). Development of a three-dimensional HPLC system for the determination of serine, threonine and allo-threonine enantiomers in the plasma of patients with chronic kidney disease. Journal of Chromatography A. 1719. 464739–464739. 3 indexed citations

Namba‐Hamano, Tomoko, Jun Nakamura, Atsushi Takahashi, et al.. (2023). A Case Report of a Kidney Transplant Recipient With Organizing Pneumonia After Graft Loss. Transplantation Proceedings. 55(4). 1081–1083.

Yasuda, Seiichi, Kazunori Inoue, Isao Matsui, et al.. (2023). Hepatic phosphate uptake and subsequent nerve-mediated phosphaturia are crucial for phosphate homeostasis following portal vein passage of phosphate in rats. Scientific Reports. 13(1). 5794–5794. 3 indexed citations

Minami, Satoshi, et al.. (2023). Autophagy and kidney aging. Progress in Biophysics and Molecular Biology. 179(2). 10–15. 11 indexed citations

Matsumoto, Ayumi, Isao Matsui, Hitoshi Mizuno, et al.. (2021). Recurrent membranous nephropathy with a possible alteration in the etiology: a case report. BMC Nephrology. 22(1). 253–253. 8 indexed citations

10.

Hesaka, Atsushi, Yusuke Tsukamoto, Shigeyuki Nada, et al.. (2021). d-Serine Mediates Cellular Proliferation for Kidney Remodeling. Kidney360. 2(10). 1611–1624. 16 indexed citations

11.

Yamamoto, Ryohei, Yasuyuki Nagasawa, Tatsuya Shoji, et al.. (2014). ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy. Journal of the Renin-Angiotensin-Aldosterone System. 16(3). 633–641. 10 indexed citations

12.

Liu, Chi, Ping Zhu, Taro Saito, et al.. (2013). Non-myeloablative conditioning is sufficient to induce mixed chimerism and subsequent acceptance of donor specific cardiac and skin grafts. International Immunopharmacology. 16(3). 392–398. 2 indexed citations

13.

Obi, Yoshitsugu, Naotsugu Ichimaru, Takayuki Hamano, et al.. (2012). Orally Active Vitamin D for Potential Chemoprevention of Posttransplant Malignancy. Cancer Prevention Research. 5(10). 1229–1235. 14 indexed citations

14.

Hamano, Takayuki, Isao Matsui, Satoshi Mikami, et al.. (2010). Fetuin-Mineral Complex Reflects Extraosseous Calcification Stress in CKD. Journal of the American Society of Nephrology. 21(11). 1998–2007. 181 indexed citations

15.

Takabatake, Yoshitsugu, Jun‐Ya Kaimori, Tomonori Kimura, et al.. (2010). CD28 superagonist-induced regulatory T cell expansion ameliorates mesangioproliferative glomerulonephritis in rats. Clinical and Experimental Nephrology. 15(1). 50–57. 11 indexed citations

16.

Tanaka, Toshiyuki, Naotsugu Ichimaru, Shiro Takahara, et al.. (2002). In Vivo Gene Transfer of Hepatocyte Growth Factor to Skeletal Muscle Prevents Changes in Rat Kidneys After 5/6 Nephrectomy. American Journal of Transplantation. 2(9). 828–836. 26 indexed citations

17.

Nakamura, Hiroyuki, Yoshitaka Isaka, Michiko Tsujie, et al.. (2002). Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial α-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Therapy. 9(8). 495–502. 52 indexed citations

18.

Nakamura, Hiroyuki, Yoshitaka Isaka, Michiko Tsujie, et al.. (2001). Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis. Kidney International. 59(6). 2134–2145. 47 indexed citations

19.

Fouqueray, Bruno, Yoshitaka Isaka, Yuya Akagi, et al.. (1996). 抗糸球体基底膜(GBM)腎炎におけるインターロイキン(IL)10遺伝子導入によるタンパク尿症の減少. Journal of the American Society of Nephrology. 7(9). 2259. 1 indexed citations

20.

Isaka, Yoshitaka, Y. Fujiwara, Naohiko Ueda, et al.. (1993). Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.. Journal of Clinical Investigation. 92(6). 2597–2601. 431 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact